此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Mobile App vs. In-Person Pelvic Floor Rehabilitation for Urinary Leakage in Adult Women

2026年5月19日 更新者:Susana Moreira、Unidade Local de Saúde São João

Randomized Controlled Non-Inferiority Trial Comparing a Mobile Application Based Program With Conventional Rehabilitation for Stress and Mixed Urinary Incontinence in Adult Women

The goal of this clinical trial is to learn if a mobile app-guided pelvic floor rehabilitation program works as well as standard in-person pelvic floor rehabilitation to treat urinary leakage in adult women.

The main question it aims to answer is:

Does the app program improve quality of life related to urinary leakage as much as in-person rehabilitation?

Researchers will compare the app-based program to in-person rehabilitation to see if both lead to similar improvements in quality of life.

Participants will:

Attend one medical visit before starting to confirm they are eligible Attend one in-person training session with a physiotherapist Follow either an app-based or an in-person pelvic floor rehabilitation program for 3 months Complete quality of life questionnaires at the start and at 4 months

研究概览

详细说明

Background

Urinary incontinence (UI) is common in women and undertreated in Portugal. Only 11% of Portuguese women with UI report having completed any rehabilitation program. Conventional pelvic floor rehabilitation requires supervised sessions two to three times per week for at least 3 to 4 months, mostly available only at tertiary hospitals. Mobile app-based programs may improve access, adherence, and convenience. However, no randomized trial has compared an app-based program directly against supervised rehabilitation as an active comparator in the Portuguese population. An important consideration in participant selection is pelvic floor muscle function. Studies show that up to 53% of women with UI cannot contract the pelvic floor correctly without prior in-person training. For this reason, the ability to voluntarily contract the pelvic floor is an inclusion criterion, confirmed at the baseline medical visit.

Study Design

This is a randomized controlled non-inferiority trial with two parallel arms conducted at the Pelvic Floor Rehabilitation Unit of the Physical and Rehabilitation Medicine (PM&R) Department of ULS São João, a tertiary academic hospital in Porto, Portugal.

The Mobile App

The app-based program was developed by the investigators in collaboration with the Information Systems and Technologies Department and the Data Intelligence Department of ULS São João. It was integrated into the existing My São João App, a platform already in use by patients of the hospital. Prior to the trial, a preliminary version was tested over one month with 10 women with prior experience in supervised pelvic floor rehabilitation and with 4 clinicians specialised in pelvic floor rehabilitation. Participants completed a structured questionnaire assessing interface usability, aesthetics, engagement, and functionality, and took part in a discussion of weaknesses and suggestions for improvement. A final version was developed based on this feedback.

Randomization

After baseline assessment, participants are randomized 1:1 into the intervention or control group by a research assistant not involved in the investigation. Allocation uses a computer-generated random sequence implemented through sequentially numbered sealed opaque envelopes, stored in a locked cabinet accessible only to the research assistant. Envelopes are opened immediately before the initial individual session. Participants and health professionals are not blinded to group allocation.

Intervention Group - App-Based Program (12 weeks)

One in-person medical consultation at the start. Participants install the app, are trained on its use, and receive lifestyle and behavioural recommendations tailored to their UI type and baseline assessment results. Three in-person individual physiotherapy sessions at weeks 0, 4, and 8. At each session, participants are trained on the exercises that will be released on the app following that session. App content includes a structured pelvic floor muscle exercise program released in 3 progressive phases, with gradual increases in duration, repetitions, and positions. Participants perform a daily sequence 3 times per day and two 30-minute sessions per week. Programmable reminders allow participants to set exercise times according to their own schedule. Daily app notifications collect feedback on the number of sessions completed and participant satisfaction. One teleconsultation at week 6 to assess adherence, motivation, side effects, and progress. At week 12, participants are notified via the app to begin the maintenance phase: the daily sequence 3 times per day, 3 days per week. One in-person medical consultation at week 16 to assess compliance and outcomes.

Control Group - Supervised Program (12 weeks)

One in-person medical consultation at the start. Participants receive lifestyle and behavioural recommendations tailored to their UI type and baseline assessment results, and a written leaflet with a pelvic floor exercise sequence to perform 3 times per day. One initial in-person individual physiotherapy session, followed by supervised face-to-face group sessions twice per week (30 minutes each), structured in 3 progressive phases matching those of the app program. One in-person medical consultation at week 6 to assess adherence, side effects, and progress. At week 12, participants are instructed to begin the maintenance phase: 3 exercise sets, 3 days per week. One in-person medical consultation at week 16 to reassess compliance and outcomes.

Assessment Schedule

Outcomes are collected by physiatrists specialised in pelvic floor rehabilitation using a digital data collection form at three time points: baseline (week 0), mid-program (week 6), and end of follow-up (week 16).

Sample Size

Sample size was calculated using WinPepi version 11.65, assuming a significance level of 5%, statistical power of 80%, and a 1:1 allocation ratio. Based on a non-inferiority margin of 10.24 points on the King's Health Questionnaire (KHQ), with standard deviations of 10.545 (intervention) and 6.23 (control), 24 participants are required (12 per group). Accounting for an estimated 33% dropout rate, the target sample is 32 participants.

Statistical Analysis

Continuous variables will be described as means with standard deviations, or medians with interquartile ranges, depending on distribution. Categorical variables will be presented as proportions. Between-group comparisons at end of program will use the independent-samples t-test for normally distributed data, or the Mann-Whitney test otherwise. Categorical variables will be compared using the Chi-square or Fisher's exact test as appropriate. A pre-specified subgroup analysis will examine adherence and clinical improvement according to age, primary diagnosis (SUI or MUI), prior treatments, condition severity, quality of life scores, marital status, educational level, profession, smartphone operating system, duration of smartphone ownership, daily hours of use, and prior experience with health-related apps. A subsequent cost-effectiveness analysis is planned.

Ethical Considerations

The study is conducted in accordance with the ethical principles of the 1964 Declaration of Helsinki and its subsequent amendments. Participation is voluntary. Eligible participants are approached at their first consultation and given a participant information sheet and written informed consent form to take home. Signed consent is confirmed at the second appointment, two weeks later. Participants may withdraw at any time without consequence. All data are anonymised prior to analysis and stored securely with password protection. Only the participant's physiatrist has access to medical records. Results will be disseminated at scientific conferences and in peer-reviewed journals.

研究类型

介入性

注册 (估计的)

32

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

学习地点

      • Porto、葡萄牙、4200-319
        • 招聘中
        • Hospital de Sao Joao

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

描述

Inclusion Criteria:

  • age >18 years
  • stress urinary incontinence (SUI) or mixed urinary incontinence with predominance of SUI
  • more than one urinary incontinence episode for week in the last month
  • pelvic floor muscle strength equal or greater than 2 assessed by Oxford Modified Rating Score

Exclusion Criteria:

  • indwelling urinary catheter
  • active pelvic neoplasia
  • pelvic organ prolapse grade greater than or equal to 2
  • active urinary tract infection or macroscopic hematuria
  • neurogenic dysfunction of the lower urinary tract
  • cognitive deficit, osteoarticular, neurological or psychiatric pathologies that prevent the realization of the therapeutic program
  • conservative or surgical treatment of UI in the last 12 months
  • pregnancy or recent childbirth (< 6 months)
  • impossibility of access or illiteracy to technological means (smartphone)
  • unavailability to attend the supervised program due to accessibility, schedule or economic reasons

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Hybrid
mobile app based treatment
Mobile app based rehabilitation protocol for Stress and Mixed Urinary Incontinence in Adult Women
有源比较器:conventional
presential
Presential rehabilitation program for Stress and Mixed Urinary Incontinence in Adult Women

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
UI-related quality of life
大体时间:At baseline and in16 weeks
UI-related quality of life using the Portuguese version of the King´s Health Questionnaire (KHQ). KHQ is a disease-specific, self-administered questionnaire designed to assess the impact of UI on quality of life in women. The responses in KHQ have a four point rating system. The eight subscales ("domains") score between 0 (best) and 100 (worst). The Symptom Severity scale is scored from 0 (best) to 30 (worst). Decreases in KHQ domain scores indicate an improvement in quality of life. The minimally important difference - the smallest change in score that subjects perceive as beneficial - is 3 points for the symptom severity scale and 5 points for all other KHQ domains.
At baseline and in16 weeks

次要结果测量

结果测量
措施说明
大体时间
UI severity
大体时间:At baseline and in16 weeks
UI severity using: the ICS pad test, the Portuguese versions of the ICIQ-bladder diary, and of the International Consultation on Incontinence Questionnaire - Short Form (ICIQ-SF). The ICS pad test has been standardized by the International Continence Society and implies drinking 500mL of water and performing a protocol of activities during 1 hour. The total amount of urine leaked is determined by weighing the pad at the end. A weight difference of 1g is considered as significative. The ICIQ-bladder diary is a standardised diary that includes records of the number of incontinence episodes. The ICIQ-UI Short Form is a self-administered questionnaire for evaluating the frequency, severity and impact on quality of life of UI. It contains 4 items: frequency of urinary incontinence; amount of leakage; overall impact of urinary incontinence; self-diagnostic item. It is scored from 0 (best) to 21 (worst), considering 2.5 points for a minimal clinically important difference.
At baseline and in16 weeks
Perception of change
大体时间:At baseline and in16 weeks
Perception of change by the patient using the Portuguese version of the Patient Global Impression of Change (PGIC) Scale. The PGIC Scale is is a global index that may be used to rate the response of a condition to a therapy. It is a transition scale consisting of a single question asking the patient to rate their urinary tract condition now, as compared with how it was prior to beginning treatment on a scale from 1 (Very much better) to 7 (Very much worse).
At baseline and in16 weeks
Sexual function
大体时间:At baseline and in16 weeks
Sexual function using the Portuguese version of the Female Sexual Functioning Index (FSFI). The FSFI is a survey measuring the sexual functioning of women over the previous 30 days in six different domains: desire, arousal, lubrication, orgasm, satisfaction and pain. Sexual disfunction severity is classified into five categories based on FSFI total scores: severe (2-7.2), moderate (7.3-14.4), mild to moderate (14.5-21.6), mild (21.7-28.1 "cutoff value"), and no sexual disfunction (28.2-36).
At baseline and in16 weeks
Symptoms of depression/anxiety
大体时间:At baseline and in 16 weeks
Symptoms of depression/anxiety using the Portuguese version of the Hospital Anxiety & Depression Scale (HADS) questionnaire. HADS is a fourteen-item scale with seven items each for anxiety and depression subscales. Scoring for each item ranges from zero to three. A subscale score >8 denotes anxiety or depression.
At baseline and in 16 weeks
Health related quality of life
大体时间:At baseline and in 16 weeks
Health related quality of life, using the Portuguese version of the EuroQol 5-Dimension 5-level (EQ-5D-5L) questionnaire. The EQ-5D-5L is a brief, generic, health status measure composed of 5 questions with Likert response options (descriptive system) and a visual analog scale (EQ-VAS). The latter asks patients to rate their own health from 0 to 100 (the worst and best imaginable health, respectively). The VAS can be used as a quantitative measure of health outcome that reflects the patient's own judgement. EQ-5D utility values can be used to calculate QALYs, which can then be used in cost-utility analysis.
At baseline and in 16 weeks
Satisfaction and adherence to treatment .
大体时间:At 16 weeks
Satisfaction and adherence to treatment using a 9-point Likert scale and the self-reported number of performed sessions registered in the app (intervention group) and reported by the therapist (control group).
At 16 weeks
Participants assessment of the app quality
大体时间:16 weeks
Participants assessment of the app quality using the Portuguese version of the User Mobile App Rating Scale (uMARS). The uMARS provides 20 items in a total of 5 subscales, 4 objective quality subscales - Engagement, Functionality, Aesthetics and Information Quality - and 1 subjective quality subscale that adds 6 items to measure the impact perceived by users of the evaluated application. All items are rated on a 5-point scale from "1. Inadequate" to "5. Excellent"; there is an option to select "N/A" if the application component is irrelevant. The quality score is calculated as follows: App Quality Mean Score = (A+B+C+D)/4, where A: Engagement Mean Score; B: Functionality Mean Score; C: Aesthetics Mean Score; D: Information Mean Score. Questions rated "N/A" are excluded from the mean score calculation. Total mean score reflects the overall app quality, higher scores indicate a better user experience.
16 weeks
Direct costs of urinary incontinence
大体时间:At baseline and in16 weeks
Direct costs of urinary incontinence with an adapted version of the Dowell-Bryant Incontinence Cost Index (DBICI). The DBICI gives a detailed measure of the direct economic costs of urinary incontinence in ambulatory home-dwelling women, with the construct validity confirmed by the significant correlation with other quantitative measures of incontinence. By substituting local prices into the test format, the index can be used in different countries.
At baseline and in16 weeks

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2026年3月26日

初级完成 (估计的)

2026年8月21日

研究完成 (估计的)

2026年8月21日

研究注册日期

首次提交

2026年5月12日

首先提交符合 QC 标准的

2026年5月12日

首次发布 (实际的)

2026年5月19日

研究记录更新

最后更新发布 (实际的)

2026年5月22日

上次提交的符合 QC 标准的更新

2026年5月19日

最后验证

2026年5月1日

更多信息

与本研究相关的术语

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅